Pages that link to "Q33804473"
Jump to navigation
Jump to search
The following pages link to Anticonvulsant hypersensitivity syndrome: incidence, prevention and management (Q33804473):
Displaying 50 items.
- Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response. (Q26800980) (← links)
- Safety profile of lamotrigine in overdose (Q28066916) (← links)
- Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review (Q30277969) (← links)
- Phenobarbital/Lamotrigine coadministration-induced blood dyscrasia in a patient with epilepsy (Q33392937) (← links)
- Should celecoxib be contraindicated in patients who are allergic to sulfonamides? Revisiting the meaning of 'sulfa' allergy (Q33944895) (← links)
- Severe skin complications in patients treated with antidepressants: a literature review. (Q33955626) (← links)
- Drug-induced liver disease (Q34057571) (← links)
- Pharmacogenetics of drug hypersensitivity (Q34118186) (← links)
- Induction of hypersensitivity to a previously tolerated antiepileptic drug by a second antiepileptic drug (Q34301402) (← links)
- Life-threatening adverse events of antiepileptic drugs (Q34416456) (← links)
- Anticonvulsant hypersensitivity syndrome in children: incidence, prevention and management (Q34558600) (← links)
- Antiepileptic hypersensitivity syndrome: clinicians beware and be aware (Q34564736) (← links)
- Drug eruptions and other adverse drug effects in aged skin (Q34576955) (← links)
- Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese (Q34617803) (← links)
- Drug-induced skin, nail and hair disorders (Q34708125) (← links)
- Reactive Metabolites and Adverse Drug Reactions: Clinical Considerations (Q35117318) (← links)
- Acute hypersensitivity syndrome caused by valproic Acid: a review of the literature and a case report (Q35119469) (← links)
- The rational use of potentially hepatotoxic medications in patients with underlying liver disease (Q35194515) (← links)
- Impact of phenytoin therapy on the skin and skin disease (Q35925673) (← links)
- Flare-up reactions in severe drug hypersensitivity: infection or ongoing T-cell hyperresponsiveness (Q36188341) (← links)
- Hydrochlorothiazide-induced noncardiogenic pulmonary edema: an underrecognized yet serious adverse drug reaction (Q36257969) (← links)
- Mechanisms of drug-induced delayed-type hypersensitivity reactions in the skin (Q36440366) (← links)
- Current understanding of delayed anticonvulsant hypersensitivity reactions (Q36444480) (← links)
- Genetic association studies in epilepsy pharmacogenomics: lessons learnt and potential applications (Q36555922) (← links)
- Anticonvulsant hypersensitivity syndrome: implications for pharmaceutical care (Q36952002) (← links)
- Mechanisms of drug-induced allergy. (Q37148433) (← links)
- Evaluation of the patients diagnosed with Stevens Johnson syndrome and toxic epidermal necrolysis: a single center experience. (Q37305421) (← links)
- Anticonvulsant hypersensitivity syndrome: an update (Q38026153) (← links)
- HLA and pharmacogenetics of drug hypersensitivity. (Q38037649) (← links)
- Stevens-Johnson syndrome and toxic epidermal necrolysis: an update on pharmacogenetics studies in drug-induced severe skin reaction (Q38629821) (← links)
- Liver dysfunction induced by systemic hypersensitivity reaction to lamotrigine: case report (Q40148105) (← links)
- Establishing causality in pediatric adverse drug reactions: use of the Naranjo probability scale (Q40182513) (← links)
- Anticonvulsant hypersensitivity syndrome associated with carbamazepine administration: Case series (Q40217280) (← links)
- A case of sulfasalazine-induced hypersensitivity syndrome confirmed by enzyme-linked immunospot assay. (Q40229782) (← links)
- DRESS syndrome. Rare and potentially lethal allergic reaction to carbamazepine - a case report (Q40244695) (← links)
- Anticonvulsant hypersensitivity syndrome: cross-reactivity with tricyclic antidepressant agents (Q40260805) (← links)
- Lamotrigine induced DRESS syndrome (Q40264063) (← links)
- Patch testing is an effective method for the diagnosis of carbamazepine-induced drug reaction, eosinophilia and systemic symptoms (DRESS) syndrome in an 8-year-old girl (Q40289501) (← links)
- First report of lamotrigine-induced drug rash with eosinophilia and systemic symptoms syndrome with pancreatitis (Q40342657) (← links)
- DRESS syndrome with fatal results induced by sodium valproate in a patient with brucellosis and a positive cytoplasmic antineutrophilic cytoplasmic antibody test result (Q40362509) (← links)
- Hypersensitivity syndrome induced by anticonvulsants: possible cross-reactivity between carbamazepine and lamotrigine (Q40381081) (← links)
- Anticonvulsant hypersensitivity syndrome closely mimicking Kawasaki disease. (Q40400847) (← links)
- Type 1 diabetes mellitus in a child with phenobarbital hypersensitivity syndrome (Q40419320) (← links)
- Probable Anticonvulsant Hypersensitivity Syndrome Due to Fosphenytoin in a Pediatric Patient with Streptococcus pneumoniae Meningitis (Q40437969) (← links)
- Differential toxicity of reactive metabolites of clindamycin and sulfonamides in HIV-infected cells: influence of HIV infection on clindamycin toxicity in vitro. (Q40460056) (← links)
- Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? (Q40473390) (← links)
- Drug hypersensitivity syndrome with lamotrigine two cases in elderly (Q40508161) (← links)
- Spectrum of anticonvulsant hypersensitivity syndrome: controversy of treatment (Q40518881) (← links)
- Drug Reaction with Eosinophilia and Systemic Symptom Syndrome Induced by Lamotrigine (Q41842618) (← links)
- Phenobarbital-induced bullous lesions in a non-comatose patient (Q41904879) (← links)